Is ROIV or RVPH more undervalued in 2026?

CirclFi compares Roivant Sciences Ltd. (ROIV) and Reviva Pharmaceuticals Holdings (RVPH) using 13 institutional-grade valuation models. ROIV has a Quality of Company score of 5.4/10 while RVPH scores 3.7/10.

Which is a better buy — ROIV or RVPH?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ROIV and RVPH valuations compare?

ROIV at $29.99 and RVPH at $0.40 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ROIV vs RVPH Valuation Comparison 2026 — Intrinsic Value Analysis

ROIV

Pharmaceutical Preparations

Roivant Sciences Ltd.

Quality

5.4

out of 10

Value Trap

SAFE

Price

$29.99

Last close

Models

12/13

Active

RVPH

Pharmaceutical Preparations

Reviva Pharmaceuticals Holdings

Quality

3.7

out of 10

Value Trap

SAFE

Price

$0.40

Last close

Models

5/13

Active

Model-by-Model Comparison

Model	Type	ROIV Fair Value	ROIV Upside	RVPH Fair Value	RVPH Upside
Bayesian DCF	Intrinsic	$11.40	-62.0%	$1.02	+153.9%
Earnings Power Value	Intrinsic	$14.83	-45.9%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.37	-98.7%	$0.03	-96.6%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ROIV vs RVPH — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ROIV vs RVPH — Which Stock Is More Undervalued?

ROIV scores higher with a 5.4/10 quality rating vs RVPH's 3.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Roivant Sciences Ltd. (ROIV) and Reviva Pharmaceuticals Holdings (RVPH) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ROIV currently trades at $29.99 with a QOC of 5.4/10, while RVPH trades at $0.40 with a QOC of 3.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).